Domestic Ebola Supplement to the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC).

 

This ELC Competing Supplement addresses priority domestic capacity building around Ebola and other emerging and highly-infectious diseases. The Competing Supplement (1) provides additional resources to accelerate ELC activities around infection control assessment and response, laboratory safety, and global migration, border interventions, and migrant health; and (2) aligns with ELC's existing purpose which is to protect the public health and safety of the American people by enhancing the capacity of public health agencies to effectively detect, respond, prevent and control known and emerging (or re-emerging) infectious diseases. This is accomplished by providing financial and technical resources to (1) strengthen epidemiologic capacity; (2) enhance laboratory capacity; (3) improve information systems; and (4) enhance collaboration among epidemiology, laboratory, and information systems components of public health departments.

Deleted 04/02/2020 (Archived.) 93.815 Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention Cooperative Agreements Not Applicable. Public Health Service Act Sections 301(a)[42 U.S.C. 241(a)] and 317(k)(2)[42 U.S.C. 247b(k)(2)]. Eligible applicants consist of state, local, and U.S. territory/possession governments currently funded under CK14-1401. Specifically, these include: all 50 states, Washington, D.C., 5 largest local health departments (Chicago, Illinois; Houston, Texas; Los Angeles, California; New York City, New York; Philadelphia, Pennsylvania;), the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau or their bona fide agents. Direct beneficiaries include all 50 states, Washington, D.C., 5 largest local health departments (Chicago, Illinois; Houston, Texas; Los Angeles, California; New York City, New York; Philadelphia, Pennsylvania;), the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau or their bona fide agents. No Credentials or documentation are required. This program is excluded from coverage under 2 CFR 200, Subpart E - Cost Principles. Preapplication coordination is required. Environmental impact information is not required for this program. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Applications that are complete and responsive will be evaluated for scientific and technical merit and receive support. CDC will not review incomplete and non-responsive applications. Applications that are complete and responsive will undergo an objective review process, receive a written critique and be scored according to the published review criteria. Successful applicants will receive a Notice of Award (NOA) from the CDC Procurement and Grants Office. The NOA shall be the only binding, authorizing document between the recipient and CDC. The NOA will be signed by an authorized Grants Management Officer. Initial award provides funds for the first budget period (usually 12 months) and the NOA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, and special conditions, if any. Contact the headquarters or regional office, as appropriate, for application deadlines. From 90 to 120 days. Time is approximate; please contact the headquarters for additional information. Not Applicable. Funding provided is one-time. Applications will be evaluated based on: (1) clearly provide a plan that includes quantitative process and outcome measures (2) provide adequate and clear information to enable the reviewer to gain a reasonable understanding of the applicant’s recent and current efforts to address the issues and (3) provide a realistic plan with activities that can be achieved in year one and subsequent years. Other criteria will be listed in the individual funding opportunity announcements. Financial and technical resources are intended to be utilized for non-research activities that (1) strengthen epidemiologic capacity; (2) enhance laboratory capacity; (3) improve information systems; and (4) enhance collaboration among epidemiology, laboratory, and information systems components of public health departments. Activities may include those that enable a public health organization to establish and maintain a capable and qualified workforce, achieve modern and well-equipped public health laboratories, implement up-to-date health information systems, and institute systems that foster communication and appropriate integration across epidemiology, laboratory, and health information systems.

Federal Financial Assistance (FA) and Direct Assistance (DA) are authorized. Project funds may be used for costs associated with planning, organizing, and the implementation of other program elements to build public health epidemiology, laboratory, and health information systems capacity. Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services (e.g., contractual support). Funds may not be used for research or clinical care. Generally, awardees may not use funds to purchase furniture. Other than for normal and recognized executive-legislative relationships, no funds may be used for (1) publicity or propaganda purposes, for the preparation, distribution, or use of any material designed to support or defeat the enactment of legislation before any legislative body, or (2) the salary or expenses of any grant or contract recipient, or agent acting for such recipient, related to any activity designed to influence the enactment of legislation, appropriations, regulation, administrative action, or Executive order proposed or pending before any legislative body. (See Additional Requirement (AR) 12 for detailed guidance on this prohibition and additional guidance on lobbying for CDC awardees). Funds awarded to grantees are fully discretionary. No program reports are required. No later than 10 days after the end of each calendar quarter, the recipients must submit a calendar quarter cash transaction report (SF-272 or top portion of the SF-425 Financial Report Form) to the Payment Management System (PMS). The reporting schedule will be based on the requirements listed in the ELC funding opportunity announcements. Funded applicants must provide an interim and annual progress report. Federal Financial Reports (SF 425) and Final Progress Report are due no more than 90 days after the end of the budget period. All reports must be submitted to the Grants Management Specialist indicated in the NoA. Federal Financial Reports (SF 425) are due no more than 90 days after the end of the budget period. Federal Financial Reports and Progress Reports are required, no more than 90 days after the end of the budget/project period. No performance monitoring is required. In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503. In accordance with the provisions of OMB Circular No. A-133 (Revised, June 24, 1997), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that receive financial assistance of $300,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $300,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. Audit info. Financial records, supporting documents, statistical records, and all other records pertinent to the grant program shall be retained for a minimum of 3 years, or until completion and resolution of any audit in process or pending resolution. In all cases records must be retained until resolution of any audit questions. Property records must be retained in accordance with 45 CFR 92.42. This program has no statutory formula.
This program has no matching requirements.
This program does not have MOE requirements. Financial assistance will be provided via one lump sum award with funds being viable for 36 months. Method of awarding/releasing assistance: lump sum. See Regional Agency Offices. Angelica O'Connor 1600 Clifton Rd, NE (MS-C18), Atlanta, Georgia 30333 Email: AMOConnor@cdc.gov Phone: 4046397379 http://www.cdc.gov 00-0000-0-0-000 - ELC Ebola related supplemental support. (Cooperative Agreements) FY 14 $0; FY 15 est $126,000,000; and FY 16 est $0 - Funds will be provided on a one-time basis as a lump sum. No Data Available. Regulations governing this program are published under 42 CFR 55b. Guidelines are available. 45 CFR 92, and also HHS Grants Policy Statement at http://www.ahrq.gov/fund/hhspolicy.htm Not Applicable.